Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q78944899)
Watch
English
Androgen blockade in prostate cancer in 2002: major benefits on survival in localized disease
scientific article published on 01 December 2002
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
12573817
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12573817%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 December 2019
title
Androgen blockade in prostate cancer in 2002: major benefits on survival in localized disease
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
12573817
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12573817%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 December 2019
main subject
prostate cancer
1 reference
based on heuristic
inferred from title
author name string
Fernand Labrie
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
12573817
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12573817%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 December 2019
publication date
1 December 2002
1 reference
stated in
Europe PubMed Central
PubMed ID
12573817
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12573817%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 December 2019
published in
Molecular and Cellular Endocrinology
1 reference
stated in
Europe PubMed Central
PubMed ID
12573817
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12573817%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 December 2019
volume
198
1 reference
stated in
Europe PubMed Central
PubMed ID
12573817
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12573817%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 December 2019
issue
1-2
1 reference
stated in
Europe PubMed Central
PubMed ID
12573817
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12573817%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 December 2019
page(s)
77-87
1 reference
stated in
Europe PubMed Central
PubMed ID
12573817
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12573817%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 December 2019
cites work
The value of screening tests in the detection of prostate cancer. Part I: Results of a retrospective evaluation of 1726 men.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900371-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Maximum androgen-blockade with medical or surgical castration in advanced prostate cancer: A meta-analysis of nine published randomized controlled trials and 4128 patients using flutamide.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900371-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900371-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900371-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The cost of prostatic cancer in a defined population
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900371-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Maximum androgen blockade in advanced prostate cancer: a meta-analysis of published randomized controlled trials using nonsteroidal antiandrogens
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900371-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A controlled trial of leuprolide with and without flutamide in prostatic carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900371-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prostate cancer. Primary hormonal treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900371-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Goserelin acetate and flutamide versus bilateral orchiectomy: a phase III EORTC trial (30853). EORTC GU Group and EORTC Data Center
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900371-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Maximal androgen blockade: final analysis of EORTC phase III trial 30853. EORTC Genito-Urinary Tract Cancer Cooperative Group and the EORTC Data Center
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900371-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term efficacy and safety of nilutamide plus castration in advanced prostate cancer, and the significance of early prostate specific antigen normalization. International Anandron Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900371-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent luteinizing hormone-releasing hormone (LH-RH) agonist in adult men**Supported in part by the National Cancer Institute of Canada; Hoechst AG, Frankf
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900371-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combined orchiectomy and external radiotherapy versus radiotherapy alone for nonmetastatic prostate cancer with or without pelvic lymph node involvement: a prospective randomized study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900371-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Would prostate cancer detected by screening with prostate-specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population-based studies in Sweden
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900371-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Orchiectomy and nilutamide or placebo as treatment of metastatic prostatic cancer in a multinational double-blind randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900371-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prostate cancer consensus hampered by lack of data
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900371-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intracrinology
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900371-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anti-androgens in treatment of prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900371-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Androgenic activity of dehydroepiandrosterone and androstenedione in the rat ventral prostate
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900371-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Diagnosis of advanced or noncurable prostate cancer can be practically eliminated by prostate-specific antigen
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900371-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900371-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900371-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Transrectal ultrasound in the diagnosis and staging of prostatic carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900371-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900371-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The burden of prostate cancer from diagnosis until death
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900371-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase III studies to compare goserelin (Zoladex) with orchiectomy and with diethylstilbestrol in treatment of prostatic carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900371-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900371-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900371-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of hormonal therapy on plasma testosterone levels in prostatic carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900371-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900371-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prostate-specific antigen-based early detection of prostate cancer--validation of screening without rectal examination
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900371-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900371-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bicalutamide (Casodex) 150 mg as immediate therapy in patients with localized or locally advanced prostate cancer significantly reduces the risk of disease progression
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900371-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0303-7207(02)00371-4
1 reference
stated in
Europe PubMed Central
PubMed ID
12573817
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12573817%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 December 2019
PubMed ID
12573817
1 reference
stated in
Europe PubMed Central
PubMed ID
12573817
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12573817%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 December 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit